Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma

Clinical trial NCT04083079 · UNKNOWN

Trial details

NCT number: NCT04083079
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Granulocyte Colony-Stimulating Factor Cost-Benefit Analysis

Start date: 2019-08-01
Primary completion: 2021-08-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.